Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis
Tomáš Kalinčík(The Royal Melbourne Hospital), John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Øivind Torkildsen(Haukeland University Hospital), Mark S. Freedman(University of Ottawa), Harold Atkins(University of Ottawa), Barbara Withers(St Vincent's Hospital Sydney), Izanne Roos(The Royal Melbourne Hospital), Eva Krasulová(Charles University), Anne Kristine Lehmann(Haukeland University Hospital), Ian Sutton(The University of Sydney), Jennifer Massey(UNSW Sydney), Eva Havrdová(Charles University), Joachim Burman(Uppsala University), Marek Trněný(Charles University), Lars Bø(Haukeland University Hospital), Tomáš Kozák(The University of Texas System), Lars Bø(Haukeland University Hospital), Richard Macdonell, Basil Sharrack(Sheffield Teaching Hospitals NHS Foundation Trust), Sifat Sharmin(The Royal Melbourne Hospital)
Cited by 10
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Axonal Transection in the Lesions of Multiple Sclerosis
|New England Journal of Medicine|1998|4k
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750